These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

981 related items for PubMed ID: 16020958

  • 1. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S, Kaur J, Kumar A, Chakravarti N, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R.
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [Abstract] [Full Text] [Related]

  • 2. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R.
    Clin Cancer Res; 2005 Mar 15; 11(6):2272-84. PubMed ID: 15788677
    [Abstract] [Full Text] [Related]

  • 3. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
    Nasser W, Flechtenmacher C, Holzinger D, Hofele C, Bosch FX.
    J Oral Pathol Med; 2011 Sep 15; 40(8):629-35. PubMed ID: 21435003
    [Abstract] [Full Text] [Related]

  • 4. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP.
    J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102
    [Abstract] [Full Text] [Related]

  • 5. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 15; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 6. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun 15; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 7. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
    Kishimoto I, Mitomi H, Ohkura Y, Kanazawa H, Fukui N, Watanabe M.
    J Surg Oncol; 2008 Jul 01; 98(1):60-6. PubMed ID: 18484097
    [Abstract] [Full Text] [Related]

  • 8. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I.
    J Pathol; 1998 Apr 01; 184(4):360-8. PubMed ID: 9664901
    [Abstract] [Full Text] [Related]

  • 9. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM, Hoffman HT, Robinson RA.
    J Clin Pathol; 2006 Jul 01; 59(7):711-5. PubMed ID: 16467168
    [Abstract] [Full Text] [Related]

  • 10. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
    Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K.
    Hepatogastroenterology; 2003 Jul 01; 50(53):1321-6. PubMed ID: 14571727
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
    Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C.
    Clin Cancer Res; 1999 Feb 01; 5(2):243-50. PubMed ID: 10037171
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [Abstract] [Full Text] [Related]

  • 15. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA.
    Cancer Res; 2000 Jul 15; 60(14):3862-71. PubMed ID: 10919661
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators.
    Ralhan R, Chakravarti N, Kaur J, Sharma C, Kumar A, Mathur M, Bahadur S, Shukla NK, Deo SV.
    Int J Cancer; 2006 Mar 01; 118(5):1077-89. PubMed ID: 16161051
    [Abstract] [Full Text] [Related]

  • 17. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E, Moro D, Gazzeri S, Brambilla C.
    J Pathol; 1999 Aug 01; 188(4):351-60. PubMed ID: 10440744
    [Abstract] [Full Text] [Related]

  • 18. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA.
    Int J Surg Pathol; 2009 Oct 01; 17(5):361-7. PubMed ID: 19666944
    [Abstract] [Full Text] [Related]

  • 19. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S, Isisag A, Saruc M, Nese N, Demir MA, Kucukmetin NT.
    Hepatogastroenterology; 2010 Oct 01; 57(98):251-6. PubMed ID: 20583423
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB, Bremmer JF, Braakhuis BJ, Heck AJ, Slijper M, van der Waal I, Brakenhoff RH.
    Oral Oncol; 2010 Feb 01; 46(2):123-7. PubMed ID: 20036603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.